Last reviewed · How we verify
NCT03032692
Motor Task Performance Under Visual and Auditory Feedback Post Stroke: a Randomized Crossover Trial
NA trial testing SWORD in Ischemic Stroke in 30 participants. Completed in 31 August 2016.
31 August 2016
Quick facts
| Lead sponsor | Sword Health, SA |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 June 2016 |
| Primary completion | 31 August 2016 |
| Estimated completion | 31 August 2016 |
| Sites | 3 locations across Portugal |
Drugs / interventions tested
- SWORD
- Exercise with biofeedback
- exercise without biofeedback
Conditions studied
- Ischemic Stroke — all drugs for Ischemic Stroke →
- Upper Extremity Paresis — all drugs for Upper Extremity Paresis →
Sponsor
Sword Health, SA
Who can join
18 and older, any sex, with Ischemic Stroke or Upper Extremity Paresis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study was designed to evaluate the impact of a novel kinematic biofeedback system - SWORD - in the motor performance of patients after stroke. The SWORD system combines inertial motion trackers and a mobile app, allowing digitization of patient motion and providing real-time audiovisual biofeedback. The investigators hypothesize that the biofeedback feedback provided by the SWORD system improves patient performance, defined as an increase in the number of correct movements. The design of the study is a cross-over randomized clinical trial. Patients will be randomized into two groups. Both will perform two separate sessions consisting of one exercise - shoulder flexion with elbow flexion at 90 degrees - for 4 minutes in both experimental settings: with and without biofeedback. Group 1 will perform the exercise with biofeedback first and without biofeedback after, with an interval \>24h. Group 2 will perform the exercise in the opposite order. The SWORD system will be used to record movement data in both sessions, but the feedback was only active in one of them.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03032692
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ischemic Stroke
Currently open trials in the same condition.
- NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
- NCT07375953 — Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK) · Phase 2 · recruiting
- NCT07375966 — Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours · Phase 2 · recruiting
- NCT07491952 — Continuous Dual Aspiration Technique With Zoom System for Stroke · recruiting
- NCT07371455 — A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants · Phase 1 · recruiting
Other Sword Health, SA trials
Trials by the same sponsor.
- NCT05417685 — Digital Care Programs for Musculoskeletal Health · enrolling by invitation
- NCT04636528 — Digital Versus Conventional Physical Therapy for Chronic Shoulder Tendinopathy · NA · completed
- NCT04808141 — Digital Care Program for Chronic Low Back Pain · NA · completed
- NCT04401683 — Home-based Exercise Rehabilitation With a Novel Digital Biofeedback System for Chronic Low Back Pain · NA · withdrawn
- NCT04092946 — Digital Home-based Rehabilitation for Musculoskeletal Disorders · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03032692 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sword Health, SA
- Last refreshed: 14 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03032692.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing